Subscribe

BIT Computer Co., Ltd (032850.KQ)

KRW3,940.00 -35.00 (-0.88%)
KR KOE Healthcare Medical - Healthcare Information Services
Address Beat Building 6621
Seoul, KR
CEO Hyun-Jung Cho
Website bit.kr
IPO 2000-09-14
ISIN KR7032850000

Explore sections of this company profile

Also trades on KOSDAQ · 032850.KQ (KRW) Korea Exchange · 032850.KS (KRW)
Description

Established in Seoul, South Korea, in 1983, BIT Computer Co., Ltd. is a specialist provider of diverse software solutions, primarily catering to the healthcare sector. Their comprehensive product suite includes a variety of hospital management systems, such as numerous Electronic Medical Record (EMR) platforms adapted for institutions ranging from small clinics to large hospitals and nursing facilities. These core offerings are enhanced by supplementary tools for tasks like insurance claim review, optimizing pharmaceutical prescriptions, intelligent nursing assistance, as well as hospital-specific enterprise resource planning (ERP) and customer relationship management (CRM) systems. The company also delivers solutions focused on patient and member engagement, encompassing cloud-based platforms, paperless clinic technology, medical image management, patient waiting systems with mobile notifications, pre-inspection services for insurance claims, and robust personal information security. Furthermore, BIT Computer provides specialized software for pharmacy management and a dedicated pharmaceutical portal. Their innovative digital health portfolio features non-contact medical services, advanced telemedicine systems, booth-based remote medical care, smart healthcare applications, employee health management tools, and medical device integration gateways.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
KRW3,940.00 -35.00 (-0.88%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
208.3K
Beta
0.44
Float Shares
10.89M
Free Float %
71.7%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
-3.11% -8.11% -20.49% -22.88% -10.09% -7.91% -14.58% -37.19% -55.95% -47.09% -41.24%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
3,940.00
DCF (Unlevered) 8,206.37 +108.3%
DCF (Levered) 7,539.56 +91.4%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Quality scores
Altman Z-Score
6.49
Safe zone
Piotroski F-Score
5 / 9
Average
MOAT Score
7 / 10
Strong MOAT
Composite Rating
A+
Overall Score
5 / 5
High
DCF Score
5 / 5
High
ROE Score
4 / 5
High
ROA Score
5 / 5
High
D/E Score
4 / 5
High
P/E Score
3 / 5
Medium
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers ★ Strong MOAT
  • Revenue growth Medical - Healthcare Information Services: +14.2%
    +10.8% Q3'25: +0.2% (vs Q3'24)
  • EPS growth Medical - Healthcare Information Services: +43.1%
    +41.7% Q3'25: -13.7% (vs Q3'24)
  • FCF margin FCF growth · Medical - Healthcare Information Services: +49.2%
    +14.0% Q3'25: +25.3% (vs Q3'24)
  • EBIT margin Medical - Healthcare Information Services: +8.8%
    +25.2% Q3'25: +17.4% (vs Q3'24)
  • ROIC Medical - Healthcare Information Services: +5.2%
    +16.8% Q3'25: +10.4% (vs Q3'24)
  • Share dilution Medical - Healthcare Information Services: -0.1%
    -1.1% Q3'25: -3.8% (vs Q3'24)
  • Debt / EBITDA Net debt/EBITDA · Medical - Healthcare Information Services: -0.74×
    0.09× Q3'25: 0.05× (vs Q3'24)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
WACC components (optional)
Ke (Cost of Equity) = Rf + β (0.58) × ERP
WACC = 99% × Ke + 1% × Kd (4.1%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
Intrinsic value (base): 8,238.58 Current price: 3,940.00
Enterprise Value: Equity Value: Terminal Value: TV as % of EV:

Base values reflect the latest available data for this company and market conditions.

Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-29 A+ 5/5 5/5 4/5 5/5 4/5 3/5 4/5
2026-05-28 A+ 4/5 4/5 4/5 5/5 4/5 3/5 4/5
2026-05-27 A+ 4/5 4/5 4/5 5/5 4/5 3/5 4/5
2026-05-26 A+ 5/5 5/5 4/5 5/5 4/5 3/5 4/5
2026-05-22 A+ 4/5 4/5 4/5 5/5 4/5 3/5 4/5
2026-05-21 A+ 4/5 4/5 4/5 5/5 4/5 3/5 4/5
2026-05-20 A+ 4/5 4/5 4/5 5/5 4/5 3/5 4/5
2026-05-19 A+ 4/5 4/5 4/5 5/5 4/5 3/5 4/5
2026-05-18 A+ 4/5 4/5 4/5 5/5 4/5 3/5 4/5
2026-05-15 A+ 4/5 4/5 4/5 5/5 4/5 3/5 4/5
2026-05-14 A+ 4/5 4/5 4/5 5/5 4/5 3/5 4/5
2026-05-13 A+ 4/5 4/5 4/5 5/5 4/5 3/5 4/5
2026-05-12 A+ 4/5 4/5 4/5 5/5 4/5 3/5 4/5
2026-05-11 A+ 4/5 4/5 4/5 5/5 4/5 3/5 4/5
2026-05-08 A+ 4/5 4/5 4/5 5/5 4/5 3/5 4/5
2026-05-07 A+ 4/5 4/5 4/5 5/5 4/5 3/5 4/5
2026-05-06 A+ 4/5 4/5 4/5 5/5 4/5 3/5 4/5
2026-05-04 A+ 4/5 4/5 4/5 5/5 3/5 4/5 4/5
2026-04-30 A 4/5 4/5 3/5 5/5 3/5 4/5 4/5
2026-04-29 A 4/5 4/5 3/5 5/5 3/5 4/5 4/5
2026-04-28 A 4/5 4/5 3/5 5/5 3/5 4/5 4/5
2026-04-27 A 4/5 4/5 3/5 5/5 3/5 4/5 4/5
2026-04-24 A 4/5 4/5 3/5 5/5 3/5 3/5 4/5
2026-04-23 A- 4/5 4/5 3/5 5/5 2/5 3/5 4/5
2026-04-22 A- 4/5 4/5 3/5 5/5 2/5 3/5 4/5
2026-04-21 A- 4/5 4/5 3/5 5/5 2/5 3/5 4/5
2026-04-20 A- 4/5 4/5 3/5 5/5 2/5 3/5 4/5
2026-04-17 A- 4/5 4/5 3/5 5/5 2/5 3/5 4/5
2026-04-16 A- 4/5 4/5 3/5 5/5 2/5 3/5 4/5
2026-04-15 A- 4/5 4/5 3/5 5/5 2/5 3/5 4/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
6.43B
OE per share TTM
408.20
Owner's Yield
9.43%
Maintenance CapEx ratio
4.80%
Maint CapEx / Avg PPE
53.2%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
Total invested
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives
EBIT / Employee
70.15M
Shares Outstanding
15.20M

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Hyun-Jung Cho Chairman & CEO male
Jin-Ok Jeon President & CEO male
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend yield history

Dividend history

Earnings reports

Stock splits